Serum interleukin-10 level in patients with inflammatory bowel disease: A meta-analysis
Interleukin-10 (IL-10) is a key anti-inflammatory cytokine, and it is associated with the pathogenesis of inflammatory bowel disease (IBD). However, the relationship between serum IL-10 level and IBD remains controversial. In this study, a meta-analysis was performed using STATA 12.0 software. Artic...
Main Authors: | Danli Meng, Liexin Liang, Xianwen Guo |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2019-04-01
|
Series: | European Journal of Inflammation |
Online Access: | https://doi.org/10.1177/2058739219843405 |
Similar Items
-
Interleukin-10 in the Pathophysiology of Inflammatory Bowel Disease: Increased Serum Concentrations During the Recovery Phase
by: Keiichi Mitsuyama, et al.
Published: (2006-01-01) -
Interleukin 10 and interleukin 10 receptor in paediatric inflammatory bowel disease: from bench to bedside lesson
by: Paulina Krawiec, et al.
Published: (2021-03-01) -
Endogenous interleukin-10 constrains Th17 cells in patients with inflammatory bowel disease
by: Wilke Cailin M, et al.
Published: (2011-12-01) -
Serum Interleukin-6 and -8 as Predictors of Response to Vedolizumab in Inflammatory Bowel Diseases
by: Lorenzo Bertani, et al.
Published: (2020-05-01) -
Serum adropin levels are reduced in patients with inflammatory bowel diseases
by: Darko Brnić, et al.
Published: (2020-06-01)